Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FR0PX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $71,855
Award facts
- Contract value 100% obligated
- $71,854.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $71.9K to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. The contract, issued on January 27, 2026, with an ultimate completion date of January 28, 2026, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The product will be delivered to Conshohocken, Pennsylvania, the location of the awardee's corporate office. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), serves as the prime contractor and is a major pharmaceutical distributor providing critical medical supply chain support to federal agencies.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999.9M and extending through December 2026. The IDC serves as the primary vehicle enabling the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Enbrel, a specialty immunosuppressant medication, represents the type of critical pharmaceutical commodity that the contract is designed to procure for military treatment facilities and other federal medical institutions. The company's role as a prime vendor in the DLA's global pharmaceutical support network underscores its significance as a key supplier for the Department of Defense's healthcare requirements.
Quick answers
Who was awarded contract SPE2DR26FR0PX?
SPE2DR26FR0PX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FR0PX worth?
The government has obligated $71,855 on SPE2DR26FR0PX.
Is contract SPE2DR26FR0PX an order under another contract?
Yes. SPE2DR26FR0PX is a delivery order under SPE2DR25D3006, an indefinite delivery contract.
Was contract SPE2DR26FR0PX competed?
The extent of competition for SPE2DR26FR0PX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award